Zacks Small Cap Research – ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements – Go Health Pro

Zacks Small Cap Research – ORMP: Preparations for New Phase 3 Trial Advance, While ORMP Leverages Balance Sheet Through Recent Agreements – Go Health Pro

By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in place Oramed Pharmaceuticals (NASDAQ:ORMP) has pivoted its clinical R&D focus to prioritize studying ORMD 0801 for subpopulations of patients with pooled specific parameters who responded well to oral insulin in its prior … Read more

Zacks Small Cap Analysis – ORMP: Steadiness Sheet Sturdy, Potential Advantages of Investments, JVs, Buybacks – Go Well being Professional

By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Stable money & equivalents place as former CFO resumes position… Oramed Prescription drugs (NASDAQ:ORMP) has named its former Chief Monetary Officer to the CFO place once more. In June 2024, the corporate named Avraham Gabay as CFO, Secretary and Treasurer to interchange former CFO David … Read more

x